Septerna, Inc. (SEPN)
41.86
-6.70
(-13.80%)
USD |
NASDAQ |
Nov 12, 16:00
41.27
-0.59
(-1.41%)
After-Hours: 20:00
Septerna Net Income (Quarterly) : -26.59M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -26.59M |
| June 30, 2026 | -13.03M |
| March 31, 2026 | -8.637M |
| December 31, 2025 | -10.74M |
| September 30, 2025 | 8.173M |
| June 30, 2025 | -24.84M |
| March 31, 2025 | -21.48M |
| Date | Value |
|---|---|
| December 31, 2024 | -20.67M |
| September 30, 2024 | -20.52M |
| June 30, 2024 | -16.44M |
| March 31, 2024 | -14.17M |
| December 31, 2023 | 31.28M |
| September 30, 2023 | -10.94M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | -3.164M |
| CNBX Pharmaceuticals, Inc. | -0.1542M |
| Arvinas, Inc. | -53.90M |
| Fulcrum Therapeutics, Inc. | -26.18M |
| Definium Therapeutics, Inc. | -50.96M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 18.88M |
| Total Expenses (Quarterly) | 45.47M |
| EPS Diluted (Quarterly) | -0.5668 |
| Enterprise Value | 1.528B |
| Gross Profit Margin (Quarterly) | 97.91% |
| Profit Margin (Quarterly) | -140.8% |
| Earnings Yield | -3.08% |
| Normalized Earnings Yield | -3.082 |